Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
8-Azidoadenosine-5′-diphosphate Sodium Salt (AC179)
Cat.#: ASSD-179
Specifications
Description 8-Azidoadenosine-5′-diphosphate Sodium Salt is potentially utilized as a photo-affinity probe commonly in combination with 32P. Synonyms 4-dihydroxy-5-[[hydroxy(phosphonooxy)phosphoryl]oxymethyl]oxolan-2-yl] purin-8-yl]imino-iminoazanium;sodium Size 1 mg, 5 mg Applications Photo-affinity probe Molecule Weight 490.2 Molecular formula C10H13N8O10P2Na CAS Number 102185-14-8 Purity >95% Solubility Soluble in methanol, and water. Form Aqueous solution Storage Store at -20° C Shipping Shipped at 4°C Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Size Price ASSD-180 Ru(bpy)2(mcbpy-O-Su-ester)(PF6)2 (AC180) 1 mg inquiry ASSD-212 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) 25 mg inquiry ASSD-116 Annexin V-FITC Apoptosis Staining / Detection Kit (AC116) 1 kit, 100 tests inquiry ASSD-143 Fluorescently labeled Muscimol TMR-X conjugate (AC143) 1mg inquiry ASSD-136 LUF7445/A2A antagonist (AC136) 50 μg inquiry ASSD-130 Calcein-AM (AC130) 1 mg inquiry ASSD-201 Fluoresceinamine Hydrochloride Isomer 1 (AC201) 2 g inquiry ASSD-176 Rhodamine B isothiocyanate (AC176) 100 mg, 500 mg inquiry ASSD-106 Hoechst 33342 Staining Solution (10mg/ml) (AC106) 5 mL, 10 mL inquiry ASSD-198 NHS-5(6)Carboxyrhodamine (AC198) 25 mg inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket